LQDA
Liquidia Corporation · Healthcare · Medical - Pharmaceuticals
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +18.8% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 99 | +23 | 36.66M | $2.92B | +26 | −3 |
| Q1 2026 | 79 | -1 | 26.51M | $999.68M | +6 | −8 |
| Q4 2025 | 81 | 0 | 26.44M | $911.45M | +1 | n/a |
| Q3 2025 | 17 | +1 | 21.94M | $498.92M | +1 | n/a |
| Q2 2025 | 13 | -2 | 14.83M | $184.82M | n/a | −2 |
| Q1 2025 | 12 | 0 | 5.71M | $84.24M | n/a | n/a |
| Q4 2024 | 12 | +4 | 4.81M | $56.51M | +4 | n/a |
| Q3 2024 | 7 | -2 | 2.07M | $20.68M | +1 | −3 |
| Q2 2024 | 9 | n/a | 2.26M | $27.08M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.79M | -1.3% | $26.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.37M | +2.5% | $20.26M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Citadel Advisors ✦ | 506.56K | +29.0% | $7.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Adage Capital Partners ✦ | 461.25K | +446.7% | $6.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 434.09K | +13.9% | $6.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Marshall Wace ✦ | 416.53K | +45.5% | $6.14M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 202.10K | -11.4% | $2.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 196.23K | +9.0% | $2.89M | 0.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 9 | D. E. Shaw & Co. ✦ | 164.37K | +1258.8% | $2.42M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 125.12K | +179.6% | $1.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 27.38K | +11.2% | $404,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 16.56K | -19.1% | $244,260 | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 242 holders, 61.34M shares, $2.26B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 7.30K sh · $207,932
Officer · 13.69K sh · $389,948
Officer · 9.22K sh · $262,529
Officer · 8.86K sh · $252,418
Officer · 5.25K sh · $149,378
Officer · 1.10K sh · $31,356
Officer · 18.94K sh · $539,354
Officer, Director · 32.74K sh · $932,549
Officer · 5.89K sh · $167,804
Director · 235.48K sh · $6.39M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology